These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37173350)

  • 1. Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma.
    Gong XQ; Liu N; Tao YY; Li L; Li ZM; Yang L; Zhang XM
    Sci Rep; 2023 May; 13(1):7710. PubMed ID: 37173350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomic analysis based on magnetic resonance imaging for the prediction of VEGF expression in hepatocellular carcinoma patients.
    Yang C; Zhang ZM; Zhao ZP; Wang ZQ; Zheng J; Xiao HJ; Xu H; Liu H; Yang L
    Abdom Radiol (NY); 2024 Nov; 49(11):3824-3833. PubMed ID: 38896246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
    Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
    Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of microvascular invasion in hepatocellular carcinoma patients with MRI radiomics based on susceptibility weighted imaging and T2-weighted imaging.
    Geng Z; Wang S; Ma L; Zhang C; Guan Z; Zhang Y; Yin S; Lian S; Xie C
    Radiol Med; 2024 Aug; 129(8):1130-1142. PubMed ID: 38997568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
    Yang X; Yuan C; Zhang Y; Wang Z
    Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics.
    Liu N; Wu Y; Tao Y; Zheng J; Huang X; Yang L; Zhang X
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCE-MRI-based radiomics in predicting angiopoietin-2 expression in hepatocellular carcinoma.
    Zheng J; Du PZ; Yang C; Tao YY; Li L; Li ZM; Yang L
    Abdom Radiol (NY); 2023 Nov; 48(11):3343-3352. PubMed ID: 37495746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
    Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
    Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma.
    Tao YY; Shi Y; Gong XQ; Li L; Li ZM; Yang L; Zhang XM
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of therapeutic response of unresectable hepatocellular carcinoma to hepatic arterial infusion chemotherapy based on pretherapeutic MRI radiomics and Albumin-Bilirubin score.
    Zhao Y; Huang F; Liu S; Jian L; Xia X; Lin H; Liu J
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5181-5192. PubMed ID: 36369395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [
    Zhao X; Zhao Y; Zhang J; Zhang Z; Liu L; Zhao X
    EJNMMI Res; 2023 Jan; 13(1):4. PubMed ID: 36682020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.
    Wu Q; Yu YX; Zhang T; Zhu WJ; Fan YF; Wang XM; Hu CH
    J Magn Reson Imaging; 2023 Apr; 57(4):1185-1196. PubMed ID: 36190656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral and Peritumoral Radiomics Based on Preoperative MRI for Evaluation of Programmed Cell Death Ligand-1 Expression in Breast Cancer.
    Wu Z; Lin Q; Wang H; Chen J; Wang G; Fu G; Li L; Bian T
    J Magn Reson Imaging; 2024 Aug; 60(2):588-599. PubMed ID: 37916918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of glypican-3 expression in hepatocellular carcinoma using multisequence magnetic resonance imaging-based histology nomograms.
    Li SQ; Yang CX; Wu CM; Cui JJ; Wang JN; Yin XP
    Quant Imaging Med Surg; 2024 Jul; 14(7):4436-4449. PubMed ID: 39022267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
    Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
    J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics-based distinction of small (≤2 cm) hepatocellular carcinoma and precancerous lesions based on unenhanced MRI.
    Gao X; Bian J; Luo J; Guo K; Xiang Y; Liu H; Ding J
    Clin Radiol; 2024 May; 79(5):e659-e664. PubMed ID: 38341345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma pathologic grade prediction using radiomics and machine learning models of gadoxetic acid-enhanced MRI: a two-center study.
    Han YE; Cho Y; Kim MJ; Park BJ; Sung DJ; Han NY; Sim KC; Park YS; Park BN
    Abdom Radiol (NY); 2023 Jan; 48(1):244-256. PubMed ID: 36131163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.